Edition:
United States

Galmed Pharmaceuticals Ltd (GLMD.OQ)

GLMD.OQ on NASDAQ Stock Exchange Capital Market

7.10USD
11:54am EST
Change (% chg)

$-0.38 (-5.08%)
Prev Close
$7.48
Open
$7.50
Day's High
$7.73
Day's Low
$7.07
Volume
15,443
Avg. Vol
22,538
52-wk High
$27.06
52-wk Low
$4.85

Chart for

About

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product candidate,... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $157.11
Shares Outstanding(Mil.): 21.00
Dividend: --
Yield (%): --

Financials

  GLMD.OQ Industry Sector
P/E (TTM): -- 86.96 36.27
EPS (TTM): -0.67 -- --
ROI: -20.10 10.17 12.64
ROE: -20.14 10.42 13.67

Earnings vs. Estimates